Evidence-Based Laboratory Medicine (EBLM)

How important are laboratory results in clinical decision making? Are they as valuable in acute myocardial infarction as for a patient suffering from a common cold? Where is the evidence – and do we have enough data to support better patient outcome?

Choosing the right laboratory test at the right time has become increasingly important particularly in improving and speeding up the diagnostic process and reducing diagnostic errors and costs.

Evidence-Based Laboratory Medicine is the leading theme on Thursday 9th of February, 2017 in International Congress on Quality in Laboratory Medicine, Helsinki, Finland.

Highlights from the scientific program

Where Is the Evidence? Demonstrating the Value of Laboratory Medicine, Mike Hallworth, UK
 

Applying the Principles of Evidence-Based Laboratory Medicine, Christopher Price, Honorary Senior Fellow, University of Oxford, UK

Quality Control in Evidence-Based Laboratory Medicine, Jérémie Gras, Clinical Biologist, Clinique Saint-Luc Bouge, Belgium

Innovative European Strategies in Predictive, Preventive and Personalised Medicine: Laboratory Medicine as the Key Player, Olga Golubnitschaja, Editor-in-Chief, The EPMA-Journal, Head of Molecular Diagnostics, University of Bonn, Germany

From Results to Consequences: the Changing Landscape of Test Evaluation, Patrick Bossuyt, Prof. of Clinical Epidemiology, University of Amsterdam, the Netherlands

International Congress on Quality in Laboratory Medicine
9th - 10th February, 2017
Helsinki, Finland

Scientific program
Registration

Read more:
International Congress on Quality in Laboratory Medicine 2017 

Source: Labquality